<DOC>
	<DOCNO>NCT00164762</DOCNO>
	<brief_summary>The purpose study determine whether addition zidovudine ( ZDV ) lamivudine ( 3TC ) onset labor seven day postpartum single-dose nevirapine ( NVP ) associate low prevalence NVP-resistant HIV compare single-dose NVP without ZDV+3TC .</brief_summary>
	<brief_title>Nevirapine Resistance Study : Nevirapine Resistance Among HIV-Infected Mothers</brief_title>
	<detailed_description>The primary purpose Nevirapine Resistance Study compare nevirapine ( NVP ) resistance HIV two six week postpartum woman participate two different program currently ongoing Lilongwe , Malawi . The first program HIV Infection Breastfeeding : Interventions Maternal Infant Health , also know Breastfeeding , Antiretrovirals Nutrition ( BAN ) Study , clinical trial enrol woman receive zidovudine ( ZDV ) lamivudine ( 3TC ) onset labor seven day postpartum addition single-dose nevirapine ( NVP ) . The second program Call Action ( CTA ) program sponsor Malawi Ministry Health Population ( MOHP ) UNC Project . The aim CTA program reduce mother child transmission ( MTCT ) HIV provide woman single dose NVP take onset labor . Study participant test NVP-resistant HIV two six week postpartum prevalence NVP-resistant virus compare among two group receive different peripartum anti-retroviral regimen .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Nevirapine</mesh_term>
	<criteria>HIV infect CD4 count &gt; 200 cells/Î¼L ALT &lt; 2.5 x upper limit normal ( ULN ) Hemoglobin ( Hb ) &gt; 7 g/dL Age &gt; 18 year , &lt; 18 year marry ( consider emancipate minor Malawi ) Ability give inform consent Evidence HIV infection , document 2 positive EnzymeLinked Immunosorbent Assays ( ELISA 's ) ; 1 positive ELISA , 1 Western blot ( WB ) ; 2 separate concurrent rapid test . These World Health Organization ( WHO ) acceptable criterion diagnose HIV1 infection adult . Currently pregnant ( single multiple fetus ) Gestation &lt; 34 week No serious current complication pregnancy Intention breastfeed Intention deliver institution study base Other HIV , active serious infection , tuberculosis potentially serious illness No previous use antiretrovirals include HIVNET 012 regimen</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2007</verification_date>
	<keyword>HIV</keyword>
	<keyword>drug resistance</keyword>
	<keyword>nevirapine</keyword>
	<keyword>anti-retroviral drug</keyword>
	<keyword>mother-to-child transmission</keyword>
	<keyword>Treatment Naive</keyword>
	<keyword>pregnancy</keyword>
</DOC>